Indeed, we found that combining Lapatinib, a dual EGFR/HER2 inhibitor, with ENZ most effectively reduced cell viability in LNCaP cells in vitro and suppressed tumor growth vivo, supporting previous findings showing HER2 inhibition augments the therapeutic effect of androgen deprivation in PCa cells [32]. Here, ERBB2 is linked to posterior cortical atrophy.